ARPA-H Provides Grant to Develop AI-Powered Solution for Nontreatable Diseases Treatment

The Advanced Research Projects Agency for Health has awarded nonprofit Every Cure a grant amounting to up to $48 million to work on the ML/AI-Aided Therapeutic Repurposing In eXtended uses project.

Renee Wegrzyn, ARPA-H director, said that the MATRIX project is expected to deliver an artificial intelligence solution capable of going through existing medications proven to effectively treat other diseases and unlock their potential as a therapy option for rare or currently untreatable diseases.

The solution needs to be compliant with machine learning/AI standards, knowledge graphs and data models developed through the National Center for Advancing Translational Sciences’ Biomedical Data Translator Program, ARPA-H said.

The MATRIX is not the first time the program has utilized the potential of AI. It turned to the emerging technology to streamline internal operations and other ways it could help improve the health care sector.

ARPA-H is an organization within the National Institutes of Health supporting high-impact research focused on discovering biomedical and health breakthroughs to deliver transformative health solutions for everyone.

On March 21, join the Potomac Officers Club’s 5th Annual AI Summit, where federal leaders and industry experts converge to explore the transformative power of artificial intelligence.